Despite a long-standing data-science-driven investment thesis, Foresight Capital's founder Jim Tananbaum states that AI tools have not yet objectively led to increased investment returns. The technology is still maturing, highlighting a reality gap between the hype around AI in VC and its current practical impact.

Related Insights

Contrary to the popular belief that failing to adopt AI is the biggest risk, some companies may be harming their value by developing AI practices too quickly. The market and client needs may not be ready for advanced AI integration, leading to a misallocation of resources and slower-than-expected returns.

Companies feel immense pressure to integrate AI to stay competitive, leading to massive spending. However, this rush means they lack the infrastructure to measure ROI, creating a paradox of anxious investment without clear proof of value.

Ken Griffin is skeptical of AI's role in long-term investing. He argues that since AI models are trained on historical data, they excel at static problems. However, investing requires predicting a future that may not resemble the past—a dynamic, forward-looking task where these models inherently struggle.

The leadership change at Sequoia, arguably the world's top venture firm, is a strong indicator of the intense pressure the entire VC industry faces. It reflects a fear of falling behind in the AI race and the brutal reality that even the best are struggling to adapt to the new competitive landscape.

AI can quickly find data in financial reports but can't replicate an expert's ability to see crucial connections and second-order effects. This leads investors to a false sense of security, relying on a tool that provides information without the wisdom to interpret it correctly.

Analysis shows that the themes venture capitalists and media hype in any given year are significantly delayed. Breakout companies like OpenAI were founded years before their sector became a dominant trend, suggesting that investing in the current "hot" theme is a strategy for being late.

Passively reading consultant decks is insufficient for grasping AI's potential. True understanding comes from active experimentation. Firms and their portfolio companies should "get their hands dirty" by building their own AI agents and co-pilots to discover the art of the possible and apply it directly to their own operations.

While AI investment has exploded, US productivity has barely risen. Valuations are priced as if a societal transformation is complete, yet 95% of GenAI pilots fail to positively impact company P&Ls. This gap between market expectation and real-world economic benefit creates systemic risk.

In the current AI hype cycle, a common mistake is valuing startups as if they've already achieved massive growth, rather than basing valuation on actual, demonstrated traction. This "paying ahead of growth" leads to inflated valuations and high risk, a lesson from previous tech booms and busts.

While healthcare companies widely use AI for cost savings and R&D efficiency, it has not yet translated into measurable revenue or earnings growth. For equity investors, there are easier, more direct ways to invest in the AI trend, making healthcare a poor proxy for the theme until its financial impact becomes clear.